Medplus Health Services Reports Suspension of Drug License for Subsidiary Store in Odisha
Medplus Health Services Limited reported that Optival Health Solutions Private Limited, a subsidiary of the company, has faced a suspension order for a Drug License pertaining to a store in the state of Odisha.The action stems from the Dy. Drugs Controller, Southern Zone, Berhmpur, Licensing Authority, Odisha. According to the details, the authority issued an order suspending the Drug License for a five-day period for the store located at Bahadur Bagicha pada, Odisha.
The formal order was received on April 10, 2026. The basis for the action cited is Rule 65 of the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945.
The potential impact of this suspension on the company's operations was quantified in monetary terms as a potential Revenue Loss of Rs 3.80 lacs.
MEDPLUS Stock Price Movement
On Friday, Medplus Health Services Limited shares rallied to close at ₹866.85, marking a gain of 1.31%. The stock was supported by significant trading activity, which saw 151,291 shares change hands during the session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.